Moderna’s non-vaccine mRNA therapeutic can generate $278 million in 2028 if approved: GlobalData Read more
AI, Big Data will be the most impactful emerging technologies for pharma in 2023: GlobalData Read more
Inflation, drug pricing and reimbursement constraints will have the biggest negative impact on biopharma industry in 2023: GlobalData Read more
Top 20 global biopharma companies report 9.1 per cent QoQ decline in market capitalisation during Q3 2022: GlobalData Read more